Merck Sharp & Dohme Limited

Hertford Road, Hoddesdon, Hertfordshire, EN11 9BU
Telephone: +44 (0)1992 467 272
Fax: +44 (0)1992 479 292
Medical Information e-mail: medicalinformationuk@merck.com

Patient Information Leaflet last updated on the eMC: 11/05/2011
PIL Deca-Durabolin 50mg/ml

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 11/05/2011 and displayed until Current
Reasons for adding or updating:
  • Change to date of revision
  • Change to drug interactions
Updated on 03/12/2010 and displayed until 11/05/2011
Reasons for adding or updating:
  • Change to Further Information section
  • Change to date of revision
Updated on 07/07/2009 and displayed until 03/12/2010
Reasons for adding or updating:
  • Change due to user-testing of patient information
Updated on 30/06/2009 and displayed until 07/07/2009
Reasons for adding or updating:
  • Change due to user-testing of patient information
Updated on 31/10/2006 and displayed until 30/06/2009
Reasons for adding or updating:
  • Change to Further Information section
Updated on 21/07/2006 and displayed until 31/10/2006
Reasons for adding or updating:
  • Change to Further Information section
Updated on 19/02/2004 and displayed until 21/07/2006
Reasons for adding or updating:
  • Update to PIL
Updated on 23/07/2001 and displayed until 19/02/2004
Reasons for adding or updating:
  • New PIL for eMC ie a PIL for an existing product but new to the eMC

Active Ingredients/Generics

 
   nandrolone decanoate